524731 Stock Overview
Jenburkt Pharmaceuticals Limited researches and develops, manufactures, and markets pharmaceutical formulations primarily in india.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Jenburkt Pharmaceuticals Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹748.90 |
52 Week High | ₹925.00 |
52 Week Low | ₹586.90 |
Beta | 0.59 |
1 Month Change | 5.58% |
3 Month Change | -9.73% |
1 Year Change | 6.35% |
3 Year Change | 77.21% |
5 Year Change | 54.80% |
Change since IPO | 10,447.89% |
Recent News & Updates
Recent updates
Shareholder Returns
524731 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 1.7% | -2.8% | -1.5% |
1Y | 6.3% | 54.9% | 45.0% |
Return vs Industry: 524731 underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: 524731 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
524731 volatility | |
---|---|
524731 Average Weekly Movement | 4.5% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524731 has not had significant price volatility in the past 3 months.
Volatility Over Time: 524731's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 724 | Ashish Bhuta | www.jenburkt.com |
Jenburkt Pharmaceuticals Limited researches and develops, manufactures, and markets pharmaceutical formulations primarily in india. it offers products in various therapeutic areas, such as pain management, analgesic and anti-pyretics, muscle relaxants, nutraceuticals, neuropathic pain, anti-arthritic, anti-infectives, anti-fungals, anti-ulcerants/antacids, aphrodisiacs, anti-malarials, anthelmintics, and anti- diabetics, as well as consumer products. The company provides its products through stockists and super stockists to doctors, chemists, large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. It also exports its products to approximately 13 countries worldwide.
Jenburkt Pharmaceuticals Limited Fundamentals Summary
524731 fundamental statistics | |
---|---|
Market cap | ₹3.31b |
Earnings (TTM) | ₹244.49m |
Revenue (TTM) | ₹1.38b |
13.5x
P/E Ratio2.4x
P/S RatioIs 524731 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524731 income statement (TTM) | |
---|---|
Revenue | ₹1.38b |
Cost of Revenue | ₹321.72m |
Gross Profit | ₹1.06b |
Other Expenses | ₹817.03m |
Earnings | ₹244.49m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 55.40 |
Gross Margin | 76.74% |
Net Profit Margin | 17.68% |
Debt/Equity Ratio | 0.2% |
How did 524731 perform over the long term?
See historical performance and comparison